Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a report released on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Trading Down 92.0 %

NASDAQ CALA opened at $0.00 on Friday. The business’s 50-day moving average price is $0.02 and its 200 day moving average price is $0.02. Calithera Biosciences has a twelve month low of $0.00 and a twelve month high of $0.13.

Calithera Biosciences Company Profile

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

Further Reading

• Five stocks we like better than Calithera Biosciences
• How to Calculate Inflation Rate
• Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
• 3 Monster Growth Stocks to Buy Now
• Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
• Dividend Screener: How to Evaluate Dividend Stocks Before Buying
• Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges